Asit

Verify with FDA CVM →

58 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
58
Total Reports
1
Deaths Reported
170.0%
Death Rate

Active Ingredients

Asit

Administration Routes

UnknownSubcutaneousSublingualParenteral

Species Affected

Dog 53
Cat 5

Most Affected Breeds

Retriever - Labrador 6
Crossbred Canine/dog 5
Domestic Shorthair 3
Shepherd Dog - German 3
Terrier - West Highland White 2
Retriever - Golden 2
Terrier - Jack Russell 2
Terrier - Boston 2
Terrier - Bull 2
Bulldog - French 2

Most Reported Reactions

Emesis 11
Diarrhoea 10
Lethargy (see also Central nervous system depression in 'Neurological') 10
Anxiety 5
Other abnormal test result NOS 5
INEFFECTIVE, ATOPY CONTROL 5
Decreased appetite 4
Panting 4
Emesis (multiple) 4
Erythema (for urticaria see Immune SOC) 4
Gingival hyperplasia 4
Hair shedding 4

Outcome Breakdown

Ongoing
23 (39.7%)
Recovered/Normal
23 (39.7%)
Outcome Unknown
11 (19.0%)
Euthanized
1 (1.7%)

Data Summary

Metric Value
Total adverse event reports 58
Reports involving death 1
Case-fatality rate (reported events) 170.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Asit Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 58 adverse event reports referencing Asit, including 1 reports in which the animal died — a 170.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Asit. Reported administration routes include Unknown, Subcutaneous, Sublingual, Parenteral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Asit reports are Dog (53 reports), Cat (5 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (6), Crossbred Canine/dog (5), Domestic Shorthair (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Asit are Emesis (11), Diarrhoea (10), Lethargy (see also Central nervous system depression in 'Neurological') (10), Anxiety (5). Of the 58 reports with a coded outcome, Ongoing is the leading category at 39.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Asit.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial